| Old Articles: <Older 23971-23980 Newer> |
|---|
 |
The Motley Fool
June 18, 2007
Rick Aristotle Munarriz |
4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. American Eagle Outfitters... Casey's General Store... Caterpillar... Target...   |
The Motley Fool
June 18, 2007
Billy Fisher |
Elan Elevates Its Game New drug prospects push the Dublin-based biotech's shares to a new 52-week high. |
The Motley Fool
June 18, 2007
Rick Aristotle Munarriz |
3 Stocks That Blew the Market Away Beat the market and the world will beat a path to your door. Adobe... Goldman Sachs... Jamba Juice... |
The Motley Fool
June 18, 2007
S.J. Caplan |
Scouting the Latest IPOs An investor's roundup of new-issue hits, misses, and no-shows: BioFuel Energy... BWAY Holding Company... ComScore... Polypore... SemGroup... ShoreTel... etc. |
The Motley Fool
June 18, 2007
Tom Taulli |
IBM Tools Up Another Deal The latest acquisition is another sign of the importance of the software development tools business. The valuation for Telelogic is about 3.4 times revenue, and IBM has made a tender offer for the shares. |
The Motley Fool
June 18, 2007
Rick Aristotle Munarriz |
A Scuffle at the Topps Next week's Topps shareholder vote on a privatization buyout offer is being delayed to give a rival bidder a shot at the trading-card giant. |
The Motley Fool
June 18, 2007
Brian Lawler |
Gilead Gets the Payoff Gilead gets marketing approval for one of its drug candidates. Investors, take note. |
The Motley Fool
June 18, 2007
Nathan Parmelee |
Quick Take: Cadbury's Sweet Tooth Cadbury's impending split hasn't stopped it from making small acquisitions. Investors, take note. |
The Motley Fool
June 18, 2007
Brian Lawler |
The Third Time Isn't the Charm for Encysive The approvable letter for the pulmonary arterial hypertension treatment marks the third time Thelin has failed to get full approval from the FDA. Investors, take note. |
The Motley Fool
June 18, 2007
Steven Mallas |
May Day for Sony? Video game sales rose in May, and Sony's PSP did noticeably well. It seems that video games still offer an exciting area for investors to play in. |
| <Older 23971-23980 Newer> Return to current articles. |
